Losartan Potassium 25 mg/mL Topical Gel is a semisolid formulation designed for easy and precise application on the skin through a convenient pump mechanism. This gel-like consistency ensures targeted treatment and effective absorption of active ingredients. It is primarily used to manage conditions such as hypertension and certain types of chronic pain, providing localized relief and therapeutic benefits.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Losartan Potassium 25 mg/mL Topical Gel is a unique formulation that facilitates the transdermal delivery of losartan potassium directly through the skin. This semisolid gel is dispensed via a pump mechanism, allowing for easy and precise application on the targeted area.
Losartan potassium is an angiotensin II receptor blocker (ARB) commonly used in oral formulations to manage hypertension and protect renal function in patients with chronic kidney disease. When formulated as a topical gel, it may offer potential benefits for conditions where localized inhibition of angiotensin II could be advantageous. This method of delivery aims to reduce systemic exposure and potential side effects associated with oral administration, while providing targeted therapeutic effects.
For patients, this topical gel offers a non-invasive and convenient option for treatment, especially for those who may have difficulty with oral medications or are seeking localized therapy. The pump mechanism ensures accurate dosing and ease of use, enhancing adherence to the treatment regimen. It is important to apply the gel as directed by your healthcare provider to achieve the desired therapeutic outcomes.
Prescribers may consider Losartan Potassium 25 mg/mL Topical Gel for patients who could benefit from localized angiotensin II receptor blockade. The transdermal delivery system allows for direct application to the affected area, which may enhance efficacy in certain conditions while minimizing systemic absorption and associated side effects. This formulation provides an alternative route of administration that can be
Losartan Potassium 25 mg/mL Topical Gel is a unique formulation designed for transdermal delivery, allowing for localized treatment and absorption of the active ingredient through the skin. This formulation is particularly beneficial for patients who may have difficulty with oral administration or who require targeted therapy to specific areas. While topical application can reduce systemic exposure and potentially minimize some interactions, it is still crucial to be aware of possible drug interactions that may occur with Losartan Potassium, even in a topical form.
Losartan is primarily known as an angiotensin II receptor blocker (ARB), commonly used to manage hypertension and certain kidney conditions. When considering drug interactions, it is important to note that Losartan can interact with other medications that affect the renin-angiotensin system. For instance, concurrent use with other ARBs, ACE inhibitors, or aliskiren can increase the risk of hypotension, hyperkalemia, and renal impairment. Patients should be monitored closely if these combinations are deemed necessary.
Additionally, nonsteroidal anti-inflammatory drugs (NSAIDs), including over-the-counter options like ibuprofen and naproxen, may reduce the antihypertensive effects of Losartan and increase the risk of renal function deterioration. Patients using this topical gel should be advised to use NSAIDs cautiously and under medical supervision.
Potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium can lead to elevated serum potassium levels when used with Losartan. This risk is present even with topical formulations, as systemic absorption can still occur. Regular monitoring of potassium levels is recommended to prevent hyperkalemia, especially in patients with compromised renal function.
Losartan may also interact with lithium, potentially leading to increased serum lithium concentrations and toxicity. If lithium is co-administered, careful monitoring of lithium levels is advised, and dosage adjustments may be necessary.
While the topical application of Losartan Potassium may reduce the likelihood of systemic interactions compared to oral administration, it is essential for both patients and prescribers to remain vigilant. Patients should inform their healthcare providers of all medications they are taking, including over-the-counter drugs and supplements, to ensure safe and appropriate use of this formulation.
If you have any questions or need further information regarding the use of Losartan Potassium 25 mg/mL Topical Gel, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any concerns or inquiries you may have.
Losartan Potassium 25 mg/mL Topical Gel is a specialized formulation designed to deliver the active ingredient, losartan potassium, directly through the skin. This semisolid gel is dispensed via a pump mechanism, ensuring easy and precise application. The gel-like consistency allows for smooth application and absorption. By applying the gel topically, the active ingredient can be absorbed through the skin, potentially providing localized effects while minimizing systemic exposure.
Losartan potassium is primarily known as an angiotensin II receptor blocker (ARB), commonly used in oral form to manage hypertension and certain cardiovascular conditions. When applied topically, the mechanism of action remains centered around its ability to block the effects of angiotensin II, a potent vasoconstrictor. By inhibiting the binding of angiotensin II to its receptors, losartan helps to relax blood vessels, which can lead to improved blood flow and reduced blood pressure in the targeted area. This localized effect can be particularly beneficial in conditions where systemic administration is not ideal or when a focused treatment is desired.
The topical application of losartan potassium may be explored for various disease states where localized vasodilation and anti-inflammatory effects are beneficial. For instance, it could be used in the management of localized hypertension or peripheral vascular conditions. Additionally, there is potential for its use in dermatological conditions where inflammation and vasoconstriction play a role. The gel formulation allows for direct application to the affected area, providing a targeted therapeutic approach that can be adjusted in terms of dosage and frequency based on the patient's specific needs and the prescriber's recommendations.
For patients, the use of Losartan Potassium 25 mg/mL Topical Gel offers a non-invasive and convenient method of treatment. The pump mechanism ensures that the correct dose is delivered with each application, reducing the risk of over- or under-dosing. Patients should apply the gel as directed by their healthcare provider, typically to clean, dry skin, and should avoid covering the treated area with occlusive dressings unless instructed otherwise. It is important for patients to follow their prescriber's instructions regarding the frequency and duration of use to achieve optimal results.
Prescribers considering this formulation for their patients should evaluate the potential benefits of localized treatment with losartan potassium, particularly in cases where systemic side effects are a concern or when a targeted approach is more appropriate. The topical gel formulation provides flexibility in dosing and can be tailored to meet the specific therapeutic goals for each patient. As with any medication, monitoring for efficacy and any potential adverse effects is crucial to ensure safe and appropriate use.
If you have any questions or need further information about Losartan Potassium 25 mg/mL Topical Gel, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation.
Losartan Potassium 25 mg/mL Topical Gel is used for targeted treatment or absorption of active ingredients through the skin, often for localized effects or to minimize systemic exposure.
Apply the gel directly to the skin using the pump mechanism for easy and precise application. Follow your healthcare provider's instructions regarding the amount and frequency of application.
It is generally advised not to apply the gel on broken or irritated skin unless directed by a healthcare professional. Consult your doctor for specific guidance.
The pump mechanism dispenses a measured amount of the gel, ensuring consistent and precise application each time you use it.
While the gel is designed for topical use, it is important to conduct a patch test or consult with a healthcare provider to ensure it is safe for your specific skin type, especially if you have sensitive skin.
Before using Losartan Potassium Topical Gel with other topical medications, consult your healthcare provider to avoid potential interactions or adverse effects.
If you experience skin irritation, discontinue use and consult your healthcare provider for further advice. They may recommend an alternative treatment or adjust your dosage.
Store the gel at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
If you are pregnant or planning to become pregnant, consult your healthcare provider before using this gel to ensure it is safe for you and your baby.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)